Concepedia

Stefanie Hagenow

SH

Statistics

Publications

17

Citations

561

H-Index

15

Active since

2017

Affiliations

Heinrich Heine University Düsseldorf(Current)

Jagiellonian University

University of St Andrews

Goethe University Frankfurt

Instituto de Química Orgánica General

Stefanie Hagenow is an author at Heinrich Heine University Düsseldorf specializing in medicinal chemistry, pharmacology, and ligand binding.

ORCID

Publications per year

2017–2021

17

Publications

17

Multitarget‐Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H<sub>3</sub>R Antagonism for Neurodegenerative Diseases

Óscar M. Bautista‐Aguilera, Stefanie Hagenow, Alejandra Palomino‐Antolín et al. · Angewandte Chemie International Edition · 2017 · 101 citations

, , +17

Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ1-42 aggregation

Erika Plazas, Stefanie Hagenow, Mónica Constanza Ávila Murillo et al. · Bioorganic Chemistry · 2020 · 62 citations

, , +17

Novel indanone derivatives as MAO B/H3R dual-targeting ligands for treatment of Parkinson’s disease

Anna Affini, Stefanie Hagenow, Aleksandra Živković et al. · European Journal of Medicinal Chemistry · 2018 · 52 citations · Full text

, , +14

Selenazolyl-hydrazones as Novel Selective MAO Inhibitors With Antiproliferative and Antioxidant Activities: Experimental and In-silico Studies

Hana Elshaflu, Tamara R. Todorović, Milan Nikolić et al. · Frontiers in Chemistry · 2018 · 44 citations · Full text

, , +15

Search for new multi-target compounds against Alzheimer’s disease among histamine H3 receptor ligands

Marek Bajda, Dorota Łażewska, Justyna Godyń et al. · European Journal of Medicinal Chemistry · 2019 · 37 citations · Full text

, , +16

1–5 of 17